Home
/
Candel Therapeutics, Inc.
/
Financials
/
Quarterly
Candel Therapeutics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Candel Therapeutics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2023
Sep 30, 2022
$31.0K
Nov 9, 2023
Q2
2023
Jun 30, 2022
$31.0K
Aug 10, 2023
Q1
2023
Mar 31, 2022
$31.0K
May 11, 2023
Q3
2022
Sep 30, 2021
$31.0K
Nov 10, 2022
Q2
2022
Jun 30, 2021
$31.0K
Aug 5, 2022
Q1
2022
Mar 31, 2021
$31.0K
May 12, 2022
Q3
2021
Sep 30, 2020
$31.0K
Nov 12, 2021
Q2
2021
Jun 30, 2020
$31.0K
Sep 8, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($11.27M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($4.80M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
$7.38M
May 13, 2025
Q3
2025
Sep 30, 2024
($10.65M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($22.24M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($8.22M)
May 13, 2025
Q3
2024
Sep 30, 2023
($8.44M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($9.61M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($8.80M)
May 14, 2024
Q3
2023
Sep 30, 2022
($8.69M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($4.15M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($874.0K)
May 11, 2023
Q3
2022
Sep 30, 2021
($16.16M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($17.08M)
Aug 5, 2022
Q1
2022
Mar 31, 2021
($4.48M)
May 12, 2022
Q2
2021
Dec 31, 2020
($17.68M)
Sep 8, 2021
Q3
2021
Dec 31, 2020
($17.68M)
Nov 12, 2021
Q3
2021
Sep 30, 2020
($2.55M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($2.88M)
Sep 8, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($13.21M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($11.18M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($8.13M)
May 13, 2025
Q3
2025
Sep 30, 2024
($8.76M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($8.57M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($7.90M)
May 13, 2025
Q3
2024
Sep 30, 2023
($8.86M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($9.58M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($9.63M)
May 14, 2024
Q3
2023
Sep 30, 2022
($8.88M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($8.75M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($8.99M)
May 11, 2023
Q3
2022
Sep 30, 2021
($8.03M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($5.30M)
Aug 5, 2022
Q1
2022
Mar 31, 2021
($4.66M)
May 12, 2022
Q3
2021
Sep 30, 2020
($2.75M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($2.62M)
Sep 8, 2021